MedRx Co., Ltd (TYO:4586)
60.00
0.00 (0.00%)
Oct 6, 2026, 2:36 PM JST
MedRx Market Cap
MedRx has a market cap or net worth of 4.11 billion as of October 5, 2026. Its market cap has decreased by -44.29% in one year.
Market Cap
4.11B
Enterprise Value
2.97B
Revenue
121.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.00
ChartMarket Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 4.11B, a decrease of -65.04%. That is a compound annual growth rate of -7.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.11B | -35.87% |
| Dec 30, 2025 | 6.41B | 65.15% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fuji Pharma | 45.11B |
| Daito Pharmaceutical | 36.77B |
| Koa Shoji Holdings | 32.43B |
| Mizuho Medy | 32.10B |
| Pharma Foods International | 19.98B |
| Fuso Pharmaceutical Industries,Ltd. | 18.35B |
| Taiko Pharmaceutical | 12.83B |
| Wakamoto Pharmaceutical | 10.47B |